Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 7,800
Avg Vol 9,734
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 14%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Natroba for the topical treatment of head lice and scabies in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 905 602 5840
Address:
5750 Explorer Drive, Suite 404, Mississauga, Canada
Latest News on CPHRF
No data available.